Immunotherapy

As asthma and allergy continue to affect more people, the importance of advanced practitioners in enhancing patient safety, addressing health care disparities and increasing treatment access has come to the forefront of patient care.

FDA has scaled back its Risk Evaluation and Mitigation Strategy reporting requirements for providers of chimeric antigen receptor T-cell therapies.

In this video, Ronny Drapkin, MD, discusses how PARP inhibitors changed the field of ovarian cancer treatment.

Prior radiotherapy was associated with progression-free survival in patients with metastatic cutaneous squamous cell carcinoma treated with cemiplimab, according to a study.

Jae Park, MD, compared the moment to a baby being born.

A new clinic at The Ohio State University — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Pelotonia Institute for Immuno-Oncology seeks to minimize the autoimmune effects of immunotherapy cancer treatment.

Eliza Hawkes, MD, has been named the new chief clinical research officer at Olivia Newton-John Cancer Research Institute.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 ASCO Annual Meeting, as well as Healio’s top headlines from the meeting.